Peter Mollee
4PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 22, 2026
An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapy.Anthea Gibbons, Lipi Chakravorty, Hasib Sidiqi
|Jan 08, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.Shirlene Sim, Georgia McCaughan, Andrew Zannettino
|Oct 16, 2025
A collaborative approach to amyloidosis and a multidisciplinary care framework - position statement from the International Society of Amyloidosis.Vaishali Sanchorawala, Ashutosh Wechalekar, Peter Mollee
|May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16.Peter Mollee, John Reynolds, Wojt Janowski
Pageof 1
Frequent Collaborators
1 joint publications
John Reynolds
1 joint publications
Hang Quach
1 joint publications
Kerry Taylor
1 joint publications
Nicholas Weber
1 joint publications
P Joy Ho
1 joint publications
Michael Francis Leahy
1 joint publications
Vaishali Sanchorawala
1 joint publications
Ashutosh Wechalekar
1 joint publications
Yoshiki Sekijima
1 joint publications
Mathew S Maurer
